Who benefits most from second-line treatment with letrozole?

Authors
Wischnewsky, MB Schmid, P Possinger, K Bohm, R Chaudry, HA
Citation
Mb. Wischnewsky et al., Who benefits most from second-line treatment with letrozole?, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 63-84
Categorie Soggetti
Current Book Contents
Journal title
AROMATASE INHIBITION AND BREAST CANCER → ACNP
Year of publication
2001
Pages
63 - 84
Database
ISI
SICI code